Liu D - Search Results

1

WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.

Liu D, Wu C, Jiao Y, Hou L, Lu D, Zheng H, Chen C, Qian J, Fei K, Su B. Liu D, et al. Sci Rep. 2015 Jun 9;5:11114. doi: 10.1038/srep11114. Sci Rep. 2015. PMID: 26057002 Free PMC article.

2

Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients.

Cai W, Chen C, Li X, Shi J, Sun Q, Liu D, Sun Y, Hou L, Zhao X, Gu S, Wu Q, Chen H, Zhang W, Jin L, Lu D, Fei K, Su B, Qian J. Cai W, et al. Among authors: liu d. Future Oncol. 2014 May;10(7):1175-85. doi: 10.2217/fon.14.25. Future Oncol. 2014. PMID: 24947259

3

RB1 polymorphism contributes to the efficacy of platinum-taxanes in advanced squamous cell lung cancer.

Liu D, Xu W, Zhang ZW, Qian J, Zheng H, Zhang J, Su B. Liu D, et al. Asian Pac J Cancer Prev. 2015;16(2):775-81. doi: 10.7314/apjcp.2015.16.2.775. Asian Pac J Cancer Prev. 2015. PMID: 25684524 Free article.

4

Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.

Liu D, Zheng X, Chen J, Liu G, Xu Y, Shen Y, Xie L, Zhao W, Jiang G, Fan M. Liu D, et al. Among authors: liu g. Lung Cancer. 2015 Sep;89(3):249-54. doi: 10.1016/j.lungcan.2015.06.004. Epub 2015 Jun 17. Lung Cancer. 2015. PMID: 26118463

5

PTEN polymorphisms contribute to clinical outcomes of advanced lung adenocarcinoma patients treated with platinum-based chemotherapy.

Yang Y, Xu W, Liu D, Ding X, Su B, Sun Y, Gao W. Yang Y, et al. Among authors: liu d. Tumour Biol. 2016 Jun;37(6):7785-96. doi: 10.1007/s13277-015-4651-0. Epub 2015 Dec 22. Tumour Biol. 2016. PMID: 26695147

6

Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.

Yang Y, Gao W, Ding X, Xu W, Liu D, Su B, Sun Y. Yang Y, et al. Among authors: liu d. Oncotarget. 2017 Mar 7;8(10):16313-16324. doi: 10.18632/oncotarget.10771. Oncotarget. 2017. PMID: 27462918 Free PMC article.

7

Association of CHEK2 polymorphisms with the efficacy of platinum-based chemotherapy for advanced non-small-cell lung cancer in Chinese never-smoking women.

Xu W, Liu D, Yang Y, Ding X, Sun Y, Zhang B, Xu J, Su B. Xu W, et al. Among authors: liu d. J Thorac Dis. 2016 Sep;8(9):2519-2529. doi: 10.21037/jtd.2016.08.70. J Thorac Dis. 2016. PMID: 27747004 Free PMC article.

8

Genetic variants of BCL2 gene predict clinical outcomes of non-small-cell lung cancer patients treated with platinum-based chemotherapy in a Chinese population.

Ding X, Qian J, Yang Y, Xu W, Liu D, Su B. Ding X, et al. Among authors: liu d. Am J Cancer Res. 2016 Oct 1;6(10):2310-2322. eCollection 2016. Am J Cancer Res. 2016. PMID: 27822420 Free PMC article.

9

Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.

Liu D, Xu W, Ding X, Yang Y, Lu Y, Fei K, Su B. Liu D, et al. Cancer Biol Ther. 2017 Dec 2;18(12):948-957. doi: 10.1080/15384047.2016.1276128. Epub 2017 Nov 27. Cancer Biol Ther. 2017. PMID: 28278082 Free PMC article.

10

Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.

Zhang J, Fan M, Liu D, Zhao KL, Wu KL, Zhao WX, Zhu ZF, Fu XL. Zhang J, et al. Among authors: liu d. Radiat Oncol. 2017 Mar 11;12(1):51. doi: 10.1186/s13014-017-0788-x. Radiat Oncol. 2017. PMID: 28283034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,535 results

Search Page

Filters